Fifty Skolkovo hi-tech startups to showcase at Slush 20163486
Food giant Cherkizovo to open acceleration centre at Skolkovo Technopark2342
Skolkovo Ventures presented to international partners at Slush1465
Skolkovo vice president: 'We have learned how to make use of Slush'1375
Seasteading: a Silicon Valley pipedream or the future of our children?1364
Skolkovo startups win prizes for devices designed for disabled people871
Russian startups present their public security solutions in France771
Russian startups embark on investment quest at Slush startup fest in Helsinki552
ExoAtlet wins RBC award for its life-changing medical exoskeletons440
Michelin, Auchan hunt for Russian tech talent at Skolkovo325
Seasteading: a Silicon Valley pipedream or the future of our children?0
Russian startups embark on investment quest at Slush startup fest in Helsinki0
Marvelmind Robotics goes through to semifinals of Slush pitching competition in Helsinki0
Michelin, Auchan hunt for Russian tech talent at Skolkovo0
Food giant Cherkizovo to open acceleration centre at Skolkovo Technopark0
Skolkovo vice president: 'We have learned how to make use of Slush'0
Skolkovo Ventures presented to international partners at Slush0
Skolkovo startups win prizes for devices designed for disabled people0
Russian startups present their public security solutions in France0
ExoAtlet wins RBC award for its life-changing medical exoskeletons0
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland.
3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions
If confirmed, it would reportedly be the world’s first synthetic construction of a complete, transplantable living organ.
“This is undoubtedly a breakthrough in the world of regenerative medicine,” said the bioprinter’s developer Vladimir Mironov. “We have successfully demonstrated the possibilities of Russia’s first bioprinter, and we’re continuing our validation work, systematically testing and optimizing our technology for 3D organ bioprinting,” he added.
The coming weeks will see Mironov’s team attempt to transplant the organ – a matter of millimeters thick - into a mouse suffering from hyperthyroidism, the results of which will be announced at the International Bioprinting Congress in Singapore in June.
The company selected the mouse’s thyroid gland because it is relatively small and simple in design, the lab said. In transplantation, the chance of rejection is minimized by the fact that the mouse’s own stem cells were used as the foundations for the organ, the lab said.
A proud website statement simply read: “The 3D Biprinting Solutions laboratory has successfully conducted the bioprinting of an organ construct of the thyroid gland of a mouse.”
“As was promised last fall, the lab’s scientists finished their work on time – by March 15,” the statement said.
A bioprinter is a machine that fabricates living cells, a technology that could revolutionize modern medicine by providing everything from skin grafts to replacement organs.
The firm 3D Bioprinting Solutions unveiled its 3D bioprinter to the public at the Open Innovations forum in the Russian capital October 14-16.
The bioprinter works by distributing so-called tissue spheroids, or bio-ink, in successive layers in a kind of scaffold structure made of hydrogel. The gel is washed away, leaving behind three-dimensional tissue that matches a computer design down to the individual cell.
Commenting on what Mironov’s achievement means for science, Gelena Livshits, a project manager for Skolkovo’s biomed cluster, said printing an entire organ, not simply a strand of tissue as competitors in the West do, would be a “genuine sensation.”